Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Riz Ahmed"'
Autor:
David P. Duncan, Dylan Assael, Geogy Vatakencherry, Juri Bassuner, Brycen D. Bodell, Chris Molloy, Mina S. Makary, Riz Ahmed
Publikováno v:
Academic Radiology. 26:1274-1277
Objective Interventional radiology/diagnostic radiology (IR/DR) is the newest primary specialties offered to trainees, one that medical students can now apply to directly out of medical school. However, medical students are disadvantaged in that the
Autor:
Daniel Lythgoe, Waheeda Owadally, Sacha J Howell, Pippa Riddle, Iain R. Macpherson, Evandro de Azambuja, Carlo Palmieri, Rebecca Asher, Conrad Lewanski, Adam Januszewski, Barabara Stanley, Mark Beresford, Riz Ahmed, O Gojis, Felipe Ades Moraes, Deep Shah, Kelvin Yan
Publikováno v:
Cancer Research. 75:P4-15
Background: Neoadjuvant chemotherapy delivered with trastuzumab (NCT) has been shown to increase the rates of pathological complete response (pCR) compared to neoadjuvant chemotherapy (NC) alone in women with HER2 positive breast cancer (BC). pCR in
Autor:
Felipe Ades, Iain R. Macpherson, Deep Shah, Kelvin Yan, Rebecca Asher, Pippa Riddle, Barbara Stanley, Mark Beresford, Riz Ahmed, O Gojis, Daniel Lythgoe, Sacha J Howell, Evandro de Azambuja, Waheeda Owadally, Carlo Palmieri, Adam Januszewski, Conrad Lewanski
Publikováno v:
Palmieri, C, Macpherson, I R, Yan, K, Ades, F, Riddle, P, Ahmed, R, Owadally, W, Stanley, B, Shah, D, Gojis, O, Januszewski, A, Lewanski, C, Asher, R, Lythgoe, D, de Azambuja, E, Beresford, M & Howell, S J 2015, ' Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer. ', Oncotarget . https://doi.org/10.18632/oncotarget.4801
Oncotarget
Europe PubMed Central
Oncotarget
Europe PubMed Central
Neoadjuvant chemotherapy plus trastuzumab (NCT) increases the rate of pathological complete response (pCR) and event-free survival (EFS) compared to neoadjuvant chemotherapy (NC) alone in women with HER2 positive breast cancer (BC). pCR in this setti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799065be6a2b508e81762598ad227cdd
https://www.research.manchester.ac.uk/portal/en/publications/neoadjuvant-chemotherapy-and-trastuzumab-versus-neoadjuvant-chemotherapy-followed-by-postoperative-trastuzumab-for-patients-with-her2positive-breast-cancer(4f3922f0-7b54-4782-84f9-fa861ff7fbc4).html
https://www.research.manchester.ac.uk/portal/en/publications/neoadjuvant-chemotherapy-and-trastuzumab-versus-neoadjuvant-chemotherapy-followed-by-postoperative-trastuzumab-for-patients-with-her2positive-breast-cancer(4f3922f0-7b54-4782-84f9-fa861ff7fbc4).html